Podcasts Resources

Podcast: international opportunities for CBD

Written by CBD-Intel | 13th May 2020

Our managing director, Tim Phillips, discussed international CBD opportunities during the USA CBD Expo in Las Vegas in February. He examined cannabidiol developments and highlighted the number of companies and brands present in the market...

News analysis

Chinese firms eager to build home CBD market held back by lack of regulation

Written by CannIntelligence | 12th May 2020

Chinese companies hoping to build up CBD businesses are growing increasingly frustrated by a lack of rulemaking, which is inhibiting the development of the domestic market ...

News analysis

US states providing tax relief measures in midst of COVID-19

Written by CannIntelligence | 8th May 2020

Every state in the US is offering some sort of tax relief in response to the coronavirus pandemic, and many hemp and CBD companies may be eligible for such relief ...

Blogs

Did COVID-19 have much of an impact on 4/20 sales?

Written by JuditBach | 8th May 2020

The answer is not quite clear. A lot of companies reported no drop or even increases in sales compared to the previous year. There could be several reasons for this. Firstly, all cannabinoid-related products are...

News analysis

Figures from first socially distanced 4/20 reveal startling differences

Written by Freddie Dawson | 4th May 2020

Initial reports on the results of the first ever socially distanced 4/20 are a mixed bag ...

Blogs

Will COVID lead to delays in regulatory procedures?

Written by JuditBach | 1st May 2020

The ongoing pandemic lockdown looks to be ending in some areas with easing of measures in numerous jurisdictions. But the months lost – and continued social distancing measures which will not be entirely lifted in...

News analysis

The trouble with GMP – and why EU producers are at a disadvantage

Written by CBD-Intel | 30th April 2020

GMP certification means little and European CBD producers are being held back by rules limiting varieties that can be grown, new analysis from CBD-Intel reveals. Our report also explains how US and Swiss producers are...

News analysis

The world after coronavirus ‘looks bright for investment in CBD’

Written by CannIntelligence | 27th April 2020

While the global coronavirus epidemic and consequent lockdown have caused uncertainty in the cannabis sector, investments in CBD are likely to go ahead in the coming months, some experts in the industry say ...

Blogs

What aid is available for US CBD firms affected by coronavirus?

Written by JuditBach | 24th April 2020

CBD businesses in the US that have seen business impacted by the coronavirus pandemic and associated social measures could be eligible for a variety of state aid programmes. Extra funding for the programmes was just approved...

News analysis

Finnish company declares regulatory related bankruptcy

Written by CannIntelligence | 24th April 2020

Finnish authorities have cracked down on domestically based companies selling dietary supplements containing CBD, which they say lack EU authorisation, leading one of the largest importer of supplements to file for bankruptcy ...

Podcasts Resources

Podcast: CBD industry analysis during the COVID-19

Written by CBD-Intel | 24th April 2020

As the coronavirus pandemic continues, regardless of location, there is an overwhelming sense of uncertainty in the CBD industry. In this special episode, Tim Phillips – the founder and managing director of CBD-Intel — provides...

News analysis

Canada seeks experts to advise on non-prescription cannabis health products

Written by Marija Obradovic | 23rd April 2020

A new national committee is to be set up in Canada to study all aspects of non-prescription cannabis health products, including CBD products ...

News analysis

Government shutdown delays next step towards Mexican legalisation

Written by CannIntelligence | 23rd April 2020

Further advances towards the legalisation of cannabis in Mexico have been delayed by a government shutdown due to the COVID-19 pandemic, with a new deadline for legislation set by the country’s Supreme Court ...

News analysis

Emergency aid available for US businesses – but who will get it?

Written by CannIntelligence | 22nd April 2020

Most US hemp and CBD businesses should qualify for economic relief during the COVID-19 pandemic – but the type of assistance may vary dependent on qualification and availability of funds ...

News analysis

‘4/20’ celebration goes online as CBD marketing adapts to lockdown

Written by CannIntelligence | 20th April 2020

CBD companies have had to adapt marketing strategies as the COVID-19 pandemic has developed. The pandemic and the associated practice of social distancing have overtaken 4/20, the biggest promotional day for cannabis ...

News analysis

More CBD companies land in hot water with US FDA over COVID-19 claims

Written by CannIntelligence | 20th April 2020

Companies that have made claims about CBD’s beneficial effects against COVID-19 are facing swift enforcement action from US regulatory authorities ...

Blogs

How the COVID-19 crisis may impact the CBD market?

Written by JuditBach | 17th April 2020

Closures of non-essential retail will be far and away the largest factor impacting on CBD markets across the globe. It is estimated that up to 90% of offline sales in markets such as the UK...

News analysis

Clean bill of health: Epidiolex is taken off US schedule of controlled drugs

Written by CannIntelligence | 15th April 2020

The US Drug Enforcement Administration (DEA) has removed Epidiolex, the only CBD drug so far approved by the US Food and Drug Administration (FDA), from its list of controlled substances ...

News analysis

CBD companies are advised to use the time well as virus slows regulation

Written by CannIntelligence | 15th April 2020

CBD entrepreneur Christina DiArcangelo tells CBD-Intel that businesses should be using the slowdown to study, reflect, plan – and “get ahead of the ball” ...

News analysis

Anxiety, doubt – and some optimism – over coronavirus impact on CBD in US

Written by Freddie Dawson | 14th April 2020

The wider impact of COVID-19 on the CBD sector in the US remains confused in the short term and largely a mystery in the longer term as companies scramble to gather information ...